Otsuka

Proteus files for bankruptcy: Where did it falter?
MedCity News
Wed, 06/17/20 - 10:01 am
Proteus Digital Health
Otsuka
smart pills
bankruptcy
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
Xconomy
Wed, 03/11/20 - 07:26 pm
LSP
life sciences
Bristol-Myers Squibb
Otsuka
Europe
A forerunner in ‘smart pills’ adopts a new tack as key pharma partnership unravels
Stat
Tue, 01/14/20 - 10:03 am
smart pills
Proteus Digital Health
Otsuka
Otsuka's Avanir agrees to pay $108M over Neudexta kickbacks probe
Fierce Pharma
Thu, 09/26/19 - 07:44 pm
Avanir Pharmaceuticals
Otsuka
kickbacks
Neudexta
dementia
"Smart Pill" Schizophrenia Drug Unlikely To Move Payers
Forbes
Mon, 07/22/19 - 10:03 am
Otsuka
Abilify MyCite
smart pills
schizophrenia
payers
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
BioSpace
Fri, 06/7/19 - 10:07 pm
Astex
Otsuka
clinical trials
ASTX727
myelodysplastic syndrome
CMML
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Tue, 05/21/19 - 11:07 pm
Verily
Alphabet
clinical trials
Pfizer
Novartis
Sanofi
Otsuka
Wockhardt receives US FDA approval for cancer drug
Pharmaceutical Business Review
Fri, 04/12/19 - 10:09 am
Wockhardt
decitabine
FDA
generics
Otsuka
Dacogen
myelodysplastic syndromes
3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop
Motley Fool
Sat, 03/30/19 - 12:44 pm
Alzheimer's disease
Biogen
aducanumab
Otsuka
Axsome Therapeutics
Amgen
Novartis
Avanir
AVP-786
AXS-05
AMG520
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Fierce Biotech
Wed, 02/20/19 - 06:09 pm
Cerevel Therapeutics
Pfizer
Otsuka
CMOs
Parkinson's Disease
epilepsy
Antipsychotic from Lundbeck, Otsuka flops again in PhIII trials — this time in bipolar patients
Endpoints
Thu, 02/14/19 - 05:45 pm
Lundbeck
Otsuka
brexpiprazole
anti-psychotic
schizophrenia
bipolar disorder
Otsuka, Click to develop digital therapeutics for MDD
Pharmaceutical Business Review
Fri, 01/4/19 - 09:09 am
Otsuka
Click Therapeutics
digital therapeutics
major depressive disorder
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
Fierce Biotech
Fri, 11/30/18 - 10:27 am
Lundbeck
Otsuka
brexpiprazole-sertraline
PTSD
clinical trials
Otsuka's dose-tracking digital pill charts its first course to market with Magellan
Fierce Pharma
Wed, 09/5/18 - 07:02 pm
Otsuka
Abilify MyCite
smart pills
digital pills
bipolar disorder
schizophrenia
The Line Between Drugs and Devices Continues to Blur
Medical Devices and Diagnostics Industry
Fri, 08/31/18 - 10:54 am
Otsuka
Magellan Health
drug-device combos
devices
FDA
drug ingestion tracking
The 10 most innovative medical devices of 2018
Mass Device
Sun, 08/5/18 - 07:21 pm
devices
Abbott Labs
Boston Scientific
BrainScope
Foundation Medicine
Integra LifeSciences
Koning Corporation
Medtronic
Otsuka
Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm
Stat
Thu, 08/2/18 - 12:36 pm
Abilify
compulsive behavior
Bristol-Myers Squibb
Otsuka
Otsuka’s $886M-plus drug just flopped in its first crucial PhIII trial for frontline AML
Endpoints
Tue, 07/31/18 - 10:14 am
Otsuka
SGI-110
clinical trials
AML
Otsuka Ramps Up Its Antibody Game with $430M Visterra Acquisition
Xconomy
Wed, 07/11/18 - 03:12 pm
Otsuka
Visterra
M&A
Otsuka Finds Paradise in Renal Denervation Market
Medical Devices and Diagnostics Industry
Tue, 07/10/18 - 11:01 pm
Otsuka
ReCor Medical
renal denervation
devices
M&A

Pages